CD PROJEKT (UNSP.ADR)1/4 (7CD0) - Total Liabilities
Based on the latest financial reports, CD PROJEKT (UNSP.ADR)1/4 (7CD0) has total liabilities worth €237.60 Million EUR (≈ $277.79 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CD PROJEKT (UNSP.ADR)1/4 liquid asset ratio to evaluate the company's liquid asset resilience ratio.
CD PROJEKT (UNSP.ADR)1/4 - Total Liabilities Trend (2021–2024)
This chart illustrates how CD PROJEKT (UNSP.ADR)1/4's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 7CD0 current and non-current assets.
CD PROJEKT (UNSP.ADR)1/4 Competitors by Total Liabilities
The table below lists competitors of CD PROJEKT (UNSP.ADR)1/4 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TCL Zhonghuan Renewable Energy Technology Co Ltd
SHE:002129
|
China | CN¥77.63 Billion |
|
SmartSens Technology (Shanghai) Co. Ltd. A
SHG:688213
|
China | CN¥4.92 Billion |
|
LB Group Co Ltd
SHE:002601
|
China | CN¥36.55 Billion |
|
REINET INVESTMENTS S.C.A.
F:RNT
|
Germany | €2.00 Million |
|
Ryan Specialty Group Holdings Inc
NYSE:RYAN
|
USA | $9.79 Billion |
|
L&K Engineering Co Ltd
TW:6139
|
Taiwan | NT$59.33 Billion |
|
Gerdau SA ADR
NYSE:GGB
|
USA | $28.24 Billion |
|
GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO
|
India | Rs19.57 Billion |
Liability Composition Analysis (2021–2024)
This chart breaks down CD PROJEKT (UNSP.ADR)1/4's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 7CD0 net asset quality score to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CD PROJEKT (UNSP.ADR)1/4's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CD PROJEKT (UNSP.ADR)1/4 (2021–2024)
The table below shows the annual total liabilities of CD PROJEKT (UNSP.ADR)1/4 from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €241.76 Million ≈ $282.64 Million |
+14.97% |
| 2023-12-31 | €210.28 Million ≈ $245.84 Million |
-14.13% |
| 2022-12-31 | €244.87 Million ≈ $286.27 Million |
-7.38% |
| 2021-12-31 | €264.38 Million ≈ $309.09 Million |
-- |
About CD PROJEKT (UNSP.ADR)1/4
CD Projekt S.A., together its subsidiaries, engages in the development, publishing, and digital distribution of video games for personal computers and video game consoles in Poland. It operates in two segments, CD PROJEKT RED and GOG.com. The company's product portfolio comprises Cyberpunk 2077: Phantom Liberty; Cyberpunk 2077; The Witcher 3: Wild Hunt; The Witcher 2: Assassins of Kings; The Witc… Read more